Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

IL2RA (Interleukin 2 receptor, alpha)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

IL2RA expression	Cutaneous T-cell Lymphoma	IL2RA expression	Cutaneous T-cell Lymphoma	denileukin diftitox Sensitive: A1 - Approval denileukin diftitox Sensitive : A1	denileukin diftitox Sensitive: A1 - Approval denileukin diftitox Sensitive : A1
IL2RA expression	Peripheral T-cell Lymphoma	IL2RA expression	Peripheral T-cell Lymphoma	denileukin diftitox Sensitive: C1 - Off-label denileukin diftitox Sensitive : C1	denileukin diftitox Sensitive: C1 - Off-label denileukin diftitox Sensitive : C1
IL2RA elevation	Follicular Lymphoma	IL2RA elevation	Follicular Lymphoma	duvelisib Resistant: C3 – Early Trials duvelisib Resistant : C3	duvelisib Resistant: C3 – Early Trials duvelisib Resistant : C3
IL2RA positive	Diffuse Large B Cell Lymphoma	IL2RA positive	Diffuse Large B Cell Lymphoma	Resistant: C3 – Early Trials Resistant : C3	Resistant: C3 – Early Trials Resistant : C3
IL2RA-L	Follicular Lymphoma	IL2RA-L	Follicular Lymphoma	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3
IL2R overexpression	Prostate Cancer	IL2R overexpression	Prostate Cancer	niraparib Resistant: C3 – Early Trials niraparib Resistant : C3	niraparib Resistant: C3 – Early Trials niraparib Resistant : C3
IL2RA elevation	Non Small Cell Lung Cancer	IL2RA elevation	Non Small Cell Lung Cancer	PD-L1 inhibitor Resistant: C3 – Early Trials PD-L1 inhibitor Resistant : C3	PD-L1 inhibitor Resistant: C3 – Early Trials PD-L1 inhibitor Resistant : C3
IL2RA elevation	Non Small Cell Lung Cancer	IL2RA elevation	Non Small Cell Lung Cancer	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3	PD1 inhibitor Resistant: C3 – Early Trials PD1 inhibitor Resistant : C3
IL2RA expression	Non-Hodgkin’s Lymphoma	IL2RA expression	Non-Hodgkin’s Lymphoma	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D
IL2RA expression	Colorectal Cancer	IL2RA expression	Colorectal Cancer	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D	ADCT-301 Sensitive: D – Preclinical ADCT-301 Sensitive : D